New hope for myasthenia gravis: experimental drug CNP-106 enters human trials
NCT ID NCT06106672
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called CNP-106 in 54 adults aged 18-75 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to check if the drug is safe and how it affects the immune system. Participants receive either CNP-106 or a placebo, and researchers monitor side effects and immune cell changes over 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHR MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Atlantis Research
Miami, Florida, 33173, United States
-
Barrow Neurological Institute
Phoenix, Arizona, 85013, United States
-
Infusion for Health
Brea, California, 92835, United States
-
Insight Hospital and Medical Center
Chicago, Illinois, 60608, United States
-
Insight Research Institute, Dearborn
Dearborn, Michigan, 48126, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Nerve and Muscle Center of Texas
Houston, Texas, 77030, United States
-
Ohio State University Wexner Medical Center
Colombus, Ohio, 43221, United States
-
Prolato Clinical Research Center
Houston, Texas, 77054, United States
-
Quantix Research, LLC
Miami, Florida, 33173, United States
-
University of California, Davis
Sacramento, California, 95817, United States
-
University of California, Irvine
Orange, California, 92868, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Missouri, NextGen Precision Health
Columbia, Missouri, 65211, United States
-
University of South Florida
Tampa, Florida, 33612, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
-
Yale University
New Haven, Connecticut, 06516, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking daily life unlock myasthenia gravis mysteries?
- Can engineered immune cells tame a debilitating autoimmune disease?
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can DNA reveal the roots of a rare muscle disease?
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Engineered immune cells take aim at debilitating muscle weakness